Annalisa Del Prete Selected Research

tanimilast

10/2022	The PDE4 inhibitor tanimilast shows distinct immunomodulatory properties associated with a type 2 endotype and CD141 upregulation.
4/2022	The PDE4 Inhibitor Tanimilast Restrains the Tissue-Damaging Properties of Human Neutrophils.
1/2021	The PDE4 Inhibitor Tanimilast Blunts Proinflammatory Dendritic Cell Activation by SARS-CoV-2 ssRNAs.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Annalisa Del Prete Research Topics

Disease

10	Inflammation (Inflammations) 03/2024 - 11/2003
10	Neoplasms (Cancer) 01/2024 - 03/2007
3	Stroke (Strokes) 07/2023 - 03/2011
3	Hypoxia (Hypoxemia) 07/2023 - 03/2011
3	Chronic Obstructive Pulmonary Disease (COPD) 10/2022 - 01/2021
3	Rheumatoid Arthritis 01/2021 - 01/2014
2	Neoplasm Metastasis (Metastasis) 01/2024 - 01/2011
2	Lung Neoplasms (Lung Cancer) 01/2023 - 01/2021
2	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2021 - 03/2014
2	Carcinogenesis 01/2021 - 01/2021
2	Arthritis (Polyarthritis) 03/2007 - 05/2006
2	Contact Dermatitis (Eczema, Contact) 01/2007 - 09/2004
1	Colitis 01/2023
1	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2023
1	Lung Diseases (Lung Disease) 04/2022
1	Atopic Dermatitis (Atopic Eczema) 01/2021
1	Ischemia 01/2021
1	COVID-19 01/2021
1	Brain Infarction 01/2021
1	Pathologic Neovascularization 01/2021
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 12/2017
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 12/2017
1	Multiple Sclerosis 01/2016
1	Autoimmune Diseases of the Nervous System 01/2016
1	Demyelinating Diseases (Demyelinating Disease) 01/2016
1	Cardiovascular Diseases (Cardiovascular Disease) 08/2015
1	Infections 03/2015
1	Vesicular Stomatitis 03/2015
1	Autoimmune Diseases (Autoimmune Disease) 03/2014
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2011
1	Atherosclerosis 03/2007
1	Asthma (Bronchial Asthma) 03/2007
1	Experimental Arthritis 05/2006
1	Fibrosis (Cirrhosis) 05/2006

Drug/Important Bio-Agent (IBA)

5	ChemokinesIBA 01/2017 - 11/2003
4	CytokinesIBA 01/2024 - 11/2003
4	LigandsIBA 01/2024 - 11/2003
3	Neoplasm Antigens (Tumor Antigens)IBA 01/2023 - 05/2020
3	tanimilastIBA 10/2022 - 01/2021
3	Type 4 Cyclic Nucleotide PhosphodiesterasesIBA 10/2022 - 01/2021
3	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2016
2	Transcription Factor MTF-1IBA 07/2023 - 01/2021
2	MetalsIBA 07/2023 - 01/2021
2	AntigensIBA 01/2023 - 01/2021
2	Small Cytoplasmic RNAIBA 01/2023 - 01/2023
2	Chemokine ReceptorsIBA 01/2023 - 01/2016
2	RNA (Ribonucleic Acid)IBA 01/2023 - 03/2015
2	Phosphodiesterase 4 InhibitorsIBA 04/2022 - 01/2021
2	Urethane (Ethyl Carbamate)IBA 01/2021 - 11/2019
2	Oxygen (Dioxygen)IBA 01/2021 - 03/2011
1	MicroRNAs (MicroRNA)IBA 03/2024
1	CarbohydratesIBA 01/2024
1	Immune Checkpoint InhibitorsIBA 01/2024
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 01/2024
1	Dextran SulfateIBA 01/2023
1	Bronchodilator Agents (Bronchodilators)IBA 10/2022
1	GlucocorticoidsIBA 10/2022
1	phosphatidylserine receptorIBA 01/2021
1	Immunomodulating AgentsIBA 01/2021
1	Retinaldehyde (Retinal)IBA 01/2021
1	Neuroprotective AgentsIBA 01/2021
1	Antirheumatic Agents (DMARD)IBA 01/2021
1	Transcription Factors (Transcription Factor)IBA 01/2021
1	chenodeoxycholate sulfate conjugate (CDCS)IBA 12/2017
1	Peptide Hydrolases (Proteases)FDA Link 01/2017
1	Chemotactic FactorsIBA 01/2017
1	CC ChemokinesIBA 01/2016
1	DNA (Deoxyribonucleic Acid)IBA 03/2015
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2015
1	Antiviral Agents (Antivirals)IBA 03/2015
1	InterferonsIBA 03/2015
1	Protein Isoforms (Isoforms)IBA 01/2015
1	Serum Amyloid A Protein (Serum Amyloid A)IBA 01/2015
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 01/2015
1	Biomarkers (Surrogate Marker)IBA 01/2014
1	AdipokinesIBA 01/2014
1	ChromatinIBA 03/2011
1	CobaltIBA 03/2011
1	Glucose (Dextrose)FDA LinkGeneric 03/2011
1	Firefly LuciferasesIBA 03/2011
1	cobaltous chloride (cobalt(II)chloride)IBA 03/2011
1	sodium-calcium exchanger 1IBA 03/2011
1	Hormones (Hormone)IBA 01/2011
1	Interleukin-4 (Interleukin 4)IBA 10/2010
1	OvalbuminIBA 10/2010
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 03/2007
1	Leukotriene B4IBA 03/2007
1	DinitrofluorobenzeneIBA 01/2007
1	2,4-dinitrobenzeneIBA 01/2007
1	Sulfonic AcidsIBA 01/2007
1	2,4-dinitrofluorobenzene sulfonic acidIBA 01/2007
1	Leukotriene B4 Receptors (Leukotriene B4 Receptor)IBA 05/2006
1	Leukotriene Receptors (Leukotriene Receptor)IBA 05/2006
1	Junctional Adhesion Molecule AIBA 09/2004

Therapy/Procedure

2	Immunotherapy 01/2024 - 01/2022
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2023
1	Ischemic Postconditioning 01/2021
1	Injections 01/2021
1	Therapeutics 05/2006